ADVANCED SOLID TUMOR CANCER
Clinical trials for ADVANCED SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug combo trial launches for Hard-to-Treat tumors
Disease control Recruiting nowThis early-phase trial is testing an experimental oral drug called ABBV-CLS-484, either alone or combined with other cancer treatments, in people with advanced solid tumors that have spread or cannot be removed by surgery. The study aims to find safe and tolerable doses and to se…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Calico Life Sciences LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New cancer drug BNT3214 enters human trials for advanced tumors
Disease control Recruiting nowThis study is the first time the drug BNT3214 is being tested in people. It aims to find a safe and effective dose for adults with advanced solid tumors. The trial has three parts: first, finding the best dose; then, testing it in different cancer types. About 533 participants wi…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called HC010 combined with chemotherapy in people with advanced solid tumors that have spread or cannot be removed. The main goal is to find a safe dose and check for side effects. About 331 participants will join, and researchers will also…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo aims to control advanced lung cancer
Disease control Recruiting nowThis early-stage trial tests a new drug called HC010 combined with chemotherapy in people with advanced lung cancer that has spread or come back. The main goal is to find a safe dose and check for side effects. About 328 adults will take part, and researchers will also see if the…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called LM-24C5 combined with other cancer treatments for people with advanced solid tumors that have a specific protein (CEACAM5). About 130 adults aged 18-80 whose cancer has returned or not responded to standard care will participate. The goal is to …
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New x-ray activated drug injection tested for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a treatment called X-PACT for people with advanced head and neck cancer, breast cancer, soft tissue sarcoma, or melanoma that has not responded to standard treatments. X-PACT involves injecting a drug called methoxsalen directly into the tumor an…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Immunolight, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for hard-to-treat cancers: experimental drug targets HER2-positive tumors
Disease control Recruiting nowThis study tests a drug called trastuzumab rezetecan in people with advanced solid tumors that have stopped responding to standard therapies. The drug is given every three weeks to 90 participants divided into three groups based on their cancer type. Researchers will measure how …
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New writing therapy aims to ease fear in advanced cancer patients
Symptom relief Recruiting nowThis study tests a new program called EASE, which uses a simple writing exercise to help adults with advanced cancer manage their fear of the future and related trauma symptoms. The study will include 250 people with advanced solid tumors, glioblastoma, or certain ovarian or lung…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: NA • Sponsor: University of Colorado, Boulder • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC